About the Authors
- Aastha Gupta
-
* E-mail: aastha.gupta@tballiance.org
Affiliation TB Alliance, New York, NY, United States of America
- Sandeep Juneja
-
Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol
Affiliation TB Alliance, New York, NY, United States of America
- Suvanand Sahu
-
Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol
Affiliation Stop TB Partnership, Geneva, Switzerland
- Mohammed Yassin
-
Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol
Affiliation The Global Fund, Geneva, Switzerland
- Grania Brigden
-
Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol
Affiliation The Global Fund, Geneva, Switzerland
- Eliud Wandwalo
-
Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol
Affiliation The Global Fund, Geneva, Switzerland
- Saurabh Rane
-
Affiliation Survivors Against TB, Mumbai, India
- Fuad Mirzayev
-
Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol
Affiliation World Health Organization, Geneva, Switzerland
- Matteo Zignol
-
Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol
Affiliation World Health Organization, Geneva, Switzerland
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: Aastha Gupta is a consultant to the Global Alliance for TB Drug Development (TB Alliance), a non-profit organization dedicated to the discovery and development of improved TB therapeutics. TB Alliance is funded by governments and foundations and developed pretomanid/BPaL. Sandeep Juneja is an employee of the Global Alliance for TB Drug Development (TB Alliance), a non-profit organization dedicated to the discovery and development of improved TB therapeutics. TB Alliance is funded by governments and foundations and developed pretomanid/BPaL.